99 related articles for article (PubMed ID: 9786286)
1. Precision and accuracy of self-measured peak expiratory flow rates in chronic obstructive pulmonary disease.
Murata GH; Lium DJ; Busby HK; Kapsner CO
South Med J; 1998 Oct; 91(10):919-24. PubMed ID: 9786286
[TBL] [Abstract][Full Text] [Related]
2. Time course of respiratory decompensation in chronic obstructive pulmonary disease: a prospective, double-blind study of peak flow changes prior to emergency department visits.
Murata GH; Kapsner CO; Lium DJ; Busby HK
Respir Med; 1998 Jul; 92(7):936-41. PubMed ID: 10070567
[TBL] [Abstract][Full Text] [Related]
3. A multivariate model for predicting respiratory status in patients with chronic obstructive pulmonary disease.
Murata GH; Kapsner CO; Lium DJ; Busby HK
J Gen Intern Med; 1998 Jul; 13(7):462-8. PubMed ID: 9686712
[TBL] [Abstract][Full Text] [Related]
4. Peak expiratory flow rate as a surrogate for forced expiratory volume in 1 second in COPD severity classification in Thailand.
Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C; Bumroongkit C; Deesomchok A; Theerakittikul T; Limsukon A
Int J Chron Obstruct Pulmon Dis; 2015; 10():1213-8. PubMed ID: 26150713
[TBL] [Abstract][Full Text] [Related]
5. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.
Seemungal TA; Donaldson GC; Bhowmik A; Jeffries DJ; Wedzicha JA
Am J Respir Crit Care Med; 2000 May; 161(5):1608-13. PubMed ID: 10806163
[TBL] [Abstract][Full Text] [Related]
6. Use of peak expiratory flow rate in emergency department evaluation of acute exacerbation of chronic obstructive pulmonary disease.
Emerman CL; Cydulka RK
Ann Emerg Med; 1996 Feb; 27(2):159-63. PubMed ID: 8629745
[TBL] [Abstract][Full Text] [Related]
7. Patient compliance with peak flow monitoring in chronic obstructive pulmonary disease.
Murata GH; Kapsner CO; Lium DJ; Busby HK
Am J Med Sci; 1998 May; 315(5):296-301. PubMed ID: 9587085
[TBL] [Abstract][Full Text] [Related]
8. The accuracy of a handheld portable spirometer.
Rebuck DA; Hanania NA; D'Urzo AD; Chapman KR
Chest; 1996 Jan; 109(1):152-7. PubMed ID: 8549178
[TBL] [Abstract][Full Text] [Related]
9. Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease.
Littner MR; Ilowite JS; Tashkin DP; Friedman M; Serby CW; Menjoge SS; Witek TJ
Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1136-42. PubMed ID: 10764302
[TBL] [Abstract][Full Text] [Related]
10. Periodic treatment regimens with inhaled steroids in asthma or chronic obstructive pulmonary disease. Is it possible?
van Schayck CP; van den Broek PJ; den Otter JJ; van Herwaarden CL; Molema J; van Weel C
JAMA; 1995 Jul; 274(2):161-4. PubMed ID: 7596005
[TBL] [Abstract][Full Text] [Related]
11. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
Levin DC; Little KS; Laughlin KR; Galbraith JM; Gustman PM; Murphy D; Kram JA; Hardie G; Reuter C; Ostransky D; McFarland K; Petty TL; Silvers W; Rennard SI; Mueller M; Repsher LH; Zuwallack RL; Vale R
Am J Med; 1996 Jan; 100(1A):40S-48S. PubMed ID: 8610716
[TBL] [Abstract][Full Text] [Related]
12. Heart rate-lowering efficacy and respiratory safety of ivabradine in patients with obstructive airway disease: a randomized, double-blind, placebo-controlled, crossover study.
Majewski S; Slomka S; Zielinska-Wyderkiewicz E; Ciebiada M; Gorski P
Am J Cardiovasc Drugs; 2012 Jun; 12(3):179-88. PubMed ID: 22409211
[TBL] [Abstract][Full Text] [Related]
13. A field study on follow up at 10 years of prevalence of chronic obstructive pulmonary disease & peak expiratory flow rate.
Jindal SK
Indian J Med Res; 1993 Feb; 98():20-6. PubMed ID: 8495985
[TBL] [Abstract][Full Text] [Related]
14. Respiratory effects of air pollution in chronic obstructive pulmonary disease: a three month prospective study.
Harré ES; Price PD; Ayrey RB; Toop LJ; Martin IR; Town GI
Thorax; 1997 Dec; 52(12):1040-4. PubMed ID: 9516896
[TBL] [Abstract][Full Text] [Related]
15. A randomised controlled comparison of tiotropium nd ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group.
van Noord JA; Bantje TA; Eland ME; Korducki L; Cornelissen PJ
Thorax; 2000 Apr; 55(4):289-94. PubMed ID: 10722768
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study.
Ulrik CS
Thorax; 1995 Jul; 50(7):750-4. PubMed ID: 7570409
[TBL] [Abstract][Full Text] [Related]
17. More on limitations of PEFR test.
Davidoff M
Respir Care; 1977 May; 22(5):470, 472. PubMed ID: 10325144
[No Abstract] [Full Text] [Related]
18. Patterns of variation in airflow obstruction and risk of death in clinically stable asthma.
Bohadana AB; Teculescu DB
Braz J Med Biol Res; 1985; 18(2):157-62. PubMed ID: 3830282
[TBL] [Abstract][Full Text] [Related]
19. Cosinor analysis of circadian peak expiratory flow variability in normal subjects, passive smokers, heavy smokers, patients with chronic obstructive pulmonary disease and patients with interstitial lung disease.
Casale R; Pasqualetti P
Respiration; 1997; 64(4):251-6. PubMed ID: 9257358
[TBL] [Abstract][Full Text] [Related]
20. Immediate and late asthmatic responses induced by exercise in patients with reversible airflow limitation.
Speelberg B; van den Berg NJ; Oosthoek CH; Verhoeff NP; van den Brink WT
Eur Respir J; 1989 May; 2(5):402-8. PubMed ID: 2759221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
